Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (211-220 of 457) with videos related to

Pageof 46
Sort By:
Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.
British Journal of Haematology|March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndromeYael Kusne, Talha Badar, Terra Lasho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
American Journal of Hematology|June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experienceChezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
Cancer Discovery|December 21, 2018
<i>Phf6</i> Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALLAgnieszka A Wendorff, S Aidan Quinn, Marissa Rashkovan, et al.
American Journal of Hematology|June 14, 2020
A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United StatesGordon J Ruan, Caleb J Smith, Courtney Day, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Pageof 46

Showing results (211-220 of 457) with videos related to

Sort By:
Pageof 46
Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.
Leukemia & Lymphoma|September 18, 2008
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 yearsPankaj Malhotra, William J Hogan, Mark R Litzow, et al.
British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.
British Journal of Haematology|March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndromeYael Kusne, Talha Badar, Terra Lasho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.
American Journal of Hematology|June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experienceChezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
Cancer Discovery|December 21, 2018
<i>Phf6</i> Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALLAgnieszka A Wendorff, S Aidan Quinn, Marissa Rashkovan, et al.
American Journal of Hematology|June 14, 2020
A population-based study of chronic eosinophilic leukemia-not otherwise specified in the United StatesGordon J Ruan, Caleb J Smith, Courtney Day, et al.
Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.
Pageof 46